
Drug development sponsors cannot run individual trials for all products in all indications. This results in missed opportunities. Clinical trial programs known as "basket" and "umbrella" have demonstrated that multi-product, multi-indication trials can be efficient and feasible.
Nous publions uniquement les avis qui respectent les conditions requises. Consultez nos conditions pour les avis.